In response to our findings, the galectin-9 expression level in the TMEs of human CRC tissues was strongly positively associated with CD8 + T-cell infiltration, suggesting that low galectin-9 expression in the tumor stroma could be used to identify non-T-cell-inflamed TMEs, which are less responsive to immunotherapy. This evidence concerns the gene LGALS9 and neoplasm.